Latest Articles
5 Celebs Get Candid About Sobriety, Relapse, and What Keeps Them Going - celebwell.com
5 Celebs Get Candid About Sobriety, Relapse, and What Keeps Them Going celebwell.com
Published: Sept. 23, 2026, 12:06 p.m.
Three femtech companies shortlisted for Health Tech World Award - Health Tech World
Three femtech companies shortlisted for Health Tech World Award Health Tech World
Published: Sept. 23, 2026, noon
Three femtech companies shortlisted for Health Tech World Award - htworld.co.uk
Three femtech companies shortlisted for Health Tech World Award htworld.co.uk
Published: Sept. 23, 2026, noon
New test could cut need for invasive womb cancer checks - FemTech World
New test could cut need for invasive womb cancer checks FemTech World
Published: Sept. 23, 2026, 11 a.m.
New test could cut need for invasive womb cancer checks - femtechworld.co.uk
New test could cut need for invasive womb cancer checks femtechworld.co.uk
Published: Sept. 23, 2026, 11 a.m.
Kate Tolo Says Her Quest to Be ‘the Female Bryan Johnson’ Is ‘for Women’ - WIRED
Kate Tolo Says Her Quest to Be ‘the Female Bryan Johnson’ Is ‘for Women’ WIRED
Published: Sept. 23, 2026, 10:30 a.m.
Kate Tolo Says Her Quest to Be ‘the Female Bryan Johnson’ Is ‘for Women’ - wired.com
Kate Tolo Says Her Quest to Be ‘the Female Bryan Johnson’ Is ‘for Women’ wired.com
Published: Sept. 23, 2026, 10:30 a.m.
Fgl-1 Emerges as an Oncogenic Driver Fueling Endometrial Cancer Through PI3K/AKT Signaling - Bioengineer.org
Fgl-1 Emerges as an Oncogenic Driver Fueling Endometrial Cancer Through PI3K/AKT Signaling Bioengineer.org
Published: Sept. 23, 2026, 1:24 a.m.
Fgl-1 Emerges as an Oncogenic Driver Fueling Endometrial Cancer Through PI3K/AKT Signaling - bioengineer.org
Fgl-1 Emerges as an Oncogenic Driver Fueling Endometrial Cancer Through PI3K/AKT Signaling bioengineer.org
Published: Sept. 23, 2026, 1:24 a.m.
Cancer-associated mutations in endometriosis reframe a benign disease through molecular oncology.
Endometriosis is a benign yet debilitating condition, and its molecular complexity remains unexplored. Although clinically recognized, its genetic landscape has long been overlooked. This review analyses cancer-associated mutations (CAMs) identified …
Published: Sept. 23, 2026, midnight
Link copied to clipboard!